When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OBSV - ObsEva advances Phase 3 trial for nolasiban following FDA meeting
ObsEva SA
ObsEva (NASDAQ:OBSV) announces that its recent End-of-Phase 2 (EOP2) meeting with the FDA provided clarification on key development issues for its oral oxytocin receptor antagonist nolasiban.